<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2016042427577N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2017-04-12</date_registration>
      <primary_sponsor>Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Comparision of tooth alignment and pain perception of different sizes of nickle-titanium archwires in the initial phase of fixed orthodontic treatment : randomized clinical trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparision of tooth alignment and pain perception of different sizes of nickle-titanium archwires in the initial phase of fixed orthodontic treatment : randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>81</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/22567</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>tooth alignment.</hc_freetext>
      <i_freetext>Intervention 1: After placement of brackets( 0.022 inch slot, Roth system),0.012 inch nickle titanium archwires will be inserted by elastomeric O'rings (American Orthodontics, USA) in first interventional group. The method of O'rings insertion will be dependant on clinician's judgement.&#13;
The variables of the study will be the amount of tooth alignment and pain peception after insertion of initial archwires.&#13;
At the begining of study and before placement  of brackets, impression will be taken and stone casts will be prepared to calculate the amount of irregularity index (Little's irregularity index) and vertical discrepency by digital caliper (at 0.01mm).&#13;
At 4,8 and 12 weeks intervals, impressions will be taken again and the amount of irregularity index (Little's irregularity index) and vertical discrepency will be calculated. The amount of pain will be documented in each interval.&#13;
The amount of pain will be evaluated subjectively using visual analogue scale.patients will be asked to determine pain severity by drawing a vertical line on the horizontal line of questionare and determine a number from 0 to 10. Intervention 2: After placement of brackets( 0.022 inch slot, Roth system),0.014 inch nickle titanium archwires will be inserted by elastomeric O'rings (American Orthodontics, USA) in second interventional group. The method of O'rings insertion will be dependant on clinician's judgement.&#13;
The variables of the study will be the amount of tooth alignment and pain peception after insertion of initial archwires.&#13;
At the begining of study and before placement  of brackets, impression will be taken and stone casts will be prepared to calculate the amount of irregularity index (Little's irregularity index) and vertical discrepency by digital caliper (at 0.01mm).&#13;
At 4,8 and 12 weeks intervals, impressions will be taken again and the amount of irregularity index (Little's irregularity index) and vertical discrepency will be calculated. The amount of pain will be documented in each interval.&#13;
The amount of pain will be evaluated subjectively using visual analogue scale.patients will be asked to determine pain severity by drawing a vertical line on the horizontal line of questionare and determine a number from 0 to 10. Intervention 3: After placement of brackets( 0.022 inch slot, Roth system),0.016 inch nickle titanium archwires will be inserted by elastomeric O'rings (American Orthodontics, USA) in third  interventional group. The method of O'rings insertion will be dependant on clinician's judgement.&#13;
The variables of the study will be the amount of tooth alignment and pain peception after insertion of initial archwires.&#13;
At the begining of study and before placement  of brackets, impression will be taken and stone casts will be prepared to calculate the amount of irregularity index (Little's irregularity index) and vertical discrepency by digital caliper (at 0.01mm).&#13;
At 4,8 and 12 weeks intervals, impressions will be taken again and the amount of irregularity index (Little's irregularity index) and vertical discrepency will be calculated. The amount of pain will be documented in each interval.&#13;
The amount of pain will be evaluated subjectively using visual analogue scale.patients will be asked to determine pain severity by drawing a vertical line on the horizontal line of questionare and determine a number from 0 to 10.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Aydin Sorabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz Dentistry Faculty, Golgasht street, Aazadi street</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5165687386</zip>
        <telephone>+98 41 3330 9214</telephone>
        <email>ay_sorabi@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Aydin Sohrabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz University of Medical Sciences</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5165687386</zip>
        <telephone>+98 41 3330 9214</telephone>
        <email>ay_sohrabi@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: presence of all permanant teeth except third molars; no  quadhelix  or  other  palatal  expansion  device present; no extraoral  appliance; no deep overbite;  no use of NSAIDS  before study.&#13;
Exclusion criteria: pervious orthodontic treatment; medical history or craniofacial abnormality; active periodontal disease; skeletal asymmetry; systemic diseases that might affect pain perception, or in therapy for pain conditions; previous incisor extraction; missing of incisors or canine; unwillingness of patient; vertical displacement of incisors more than 3 mm; tooth block out due to crowding.</inclusion_criteria>
      <agemin>12 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>z00-z99</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>factors influencing health status and contact with health service</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>After placement of brackets( 0.022 inch slot, Roth system),0.012 inch nickle titanium archwires will be inserted by elastomeric O'rings (American Orthodontics, USA) in first interventional group. The method of O'rings insertion will be dependant on clinician's judgement.&#13;
The variables of the study will be the amount of tooth alignment and pain peception after insertion of initial archwires.&#13;
At the begining of study and before placement  of brackets, impression will be taken and stone casts will be prepared to calculate the amount of irregularity index (Little's irregularity index) and vertical discrepency by digital caliper (at 0.01mm).&#13;
At 4,8 and 12 weeks intervals, impressions will be taken again and the amount of irregularity index (Little's irregularity index) and vertical discrepency will be calculated. The amount of pain will be documented in each interval.&#13;
The amount of pain will be evaluated subjectively using visual analogue scale.patients will be asked to determine pain severity by drawing a vertical line on the horizontal line of questionare and determine a number from 0 to 10.</i_keyword>
      <i_keyword>After placement of brackets( 0.022 inch slot, Roth system),0.014 inch nickle titanium archwires will be inserted by elastomeric O'rings (American Orthodontics, USA) in second interventional group. The method of O'rings insertion will be dependant on clinician's judgement.&#13;
The variables of the study will be the amount of tooth alignment and pain peception after insertion of initial archwires.&#13;
At the begining of study and before placement  of brackets, impression will be taken and stone casts will be prepared to calculate the amount of irregularity index (Little's irregularity index) and vertical discrepency by digital caliper (at 0.01mm).&#13;
At 4,8 and 12 weeks intervals, impressions will be taken again and the amount of irregularity index (Little's irregularity index) and vertical discrepency will be calculated. The amount of pain will be documented in each interval.&#13;
The amount of pain will be evaluated subjectively using visual analogue scale.patients will be asked to determine pain severity by drawing a vertical line on the horizontal line of questionare and determine a number from 0 to 10.</i_keyword>
      <i_keyword>After placement of brackets( 0.022 inch slot, Roth system),0.016 inch nickle titanium archwires will be inserted by elastomeric O'rings (American Orthodontics, USA) in third  interventional group. The method of O'rings insertion will be dependant on clinician's judgement.&#13;
The variables of the study will be the amount of tooth alignment and pain peception after insertion of initial archwires.&#13;
At the begining of study and before placement  of brackets, impression will be taken and stone casts will be prepared to calculate the amount of irregularity index (Little's irregularity index) and vertical discrepency by digital caliper (at 0.01mm).&#13;
At 4,8 and 12 weeks intervals, impressions will be taken again and the amount of irregularity index (Little's irregularity index) and vertical discrepency will be calculated. The amount of pain will be documented in each interval.&#13;
The amount of pain will be evaluated subjectively using visual analogue scale.patients will be asked to determine pain severity by drawing a vertical line on the horizontal line of questionare and determine a number from 0 to 10.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Tooth alignment. Timepoint: 4, 8, 12 weeks after arch wire substitution. Method of measurement: Caliper/ 0.01 mm.</prim_outcome>
      <prim_outcome>Pain level. Timepoint: Immedietly, 4, 24 and 72 hours after. Method of measurement: Standard questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-01-01</approval_date>
        <contact_name>Tabriz University of Medical Sciences</contact_name>
        <contact_address>Tabriz University of Medical Sciences, Golgasht street, Azadi street Tabriz  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
